Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Influx Healthtech Ltd (INFLUX)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: INFLUX Pharmaceuticals & Drugs | Small Cap | Influx Healthtech Share Price
BSE Share Price
Not Listed
Not Listed
Influx Healthtech Ltd (INFLUX)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: INFLUX Pharmaceuticals & Drugs | Small Cap | Influx Healthtech Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹593 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹8.9
TTM Sales
₹147 Cr.
Book Value per Share
₹43.5
P/E Ratio
28.86
Lower than its 5-year historical median
Industry PE
53.6
Price to Book (P/B)
5.88
Lower than its 5-year historical median
Price to Sales (P/S)
4.04
Lower than its 5-year historical median
EV/EBITDA
18.19
Lower than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
20.38%
Outperforms industry median
Return on Capital Employed (ROCE)
27.22%
Outperforms industry median
Return on Assets (ROA)
16.69%
Operating Profit Margin
20.3%
Net Profit Margin
13.99%
Gross Profit Margin
21.1%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
40.04%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
73.53%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹78 Cr.
Equity
₹23.2 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00
Check Before You Invest
Quality
Not GoodValuation
Somewhat OvervaluedCheck Valuation charts
Price Trend
Weak
Is Influx Healthtech Ltd a good quality company?
Influx Healthtech Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Influx Healthtech Ltd performance compare with that of its Peers?
Revenue growth of Influx Healthtech Ltd vs industry peers?
Influx Healthtech Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Influx Healthtech Ltd?
Promoters hold 73.53% of the Influx Healthtech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Influx Healthtech Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of 51.43% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Influx Healthtech Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|
| ROCE % ⓘ | 119.4% | 111.9% | 85.3% | 60.2% | 40% | - |
| Value Creation Index ⓘ | 7.5 | 7.0 | 5.1 | 3.3 | 1.9 | - |
Growth Parameters ⓘ |
||||||
| Sales ⓘ | 59.2 | 76.1 | 100 | 105 | 147 | 147 |
| Sales YoY Gr. | - | 28.5% | 31.4% | 4.9% | 40% | - |
| Adj EPS ⓘ | 2.5 | 4 | 6.1 | 7.3 | 8.5 | 8.9 |
| YoY Gr. | - | 61.6% | 54.8% | 19.4% | 16.5% | - |
| BVPS (₹) ⓘ | 2.5 | 6.4 | 12.6 | 19.9 | 43.5 | 43.5 |
| Adj Net Profit ⓘ | 4.4 | 7.2 | 11.1 | 13.3 | 19.8 | 21 |
| Cash Flow from Ops. ⓘ | 2.9 | 6.4 | 8.9 | 7.1 | 3.9 | - |
| Debt/CF from Ops. ⓘ | 0.2 | 0.1 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | 24.5% | 40% | ||||
| Adj EPS ⓘ | NA | NA | 29.2% | 16.5% | ||||
| BVPSⓘ | NA | NA | 89.3% | 118.6% | ||||
| Share Price | - | - | - | 57.1% | ||||
Key Financial Parameters ⓘ
| Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 99.6 | 89.3 | 64.6 | 45.1 | 28.9 | 20.4 |
| Op. Profit Mgn % ⓘ | 10.4 | 14.1 | 17 | 19.6 | 20.3 | NAN |
| Net Profit Mgn % ⓘ | 7.5 | 9.5 | 11.1 | 12.7 | 13.5 | 14 |
| Debt to Equity ⓘ | 0.1 | 0.1 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 0 | 76 | 77 | 127 | 142 | 0 |
| Cash Conv. Cycle ⓘ | 0 | -3 | 7 | 22 | 43 | 0 |
Valuation of Influx Healthtech - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'26 |
|---|---|
| Sales | 147 |
| Operating Expenses ⓘ + | 117 |
| Operating Profit ⓘ | 30 |
| Operating Profit Margin (%) | 20.3% |
| Other Income ⓘ + | 1 |
| Interest ⓘ | 0 |
| Depreciation ⓘ | 4 |
| Profit Before Tax ⓘ | 27 |
| Tax ⓘ | 7 |
| Profit After Tax | 21 |
| PAT Margin (%) | 14.0% |
| Adjusted EPS (₹) | 8.9 |
| Dividend Payout Ratio (%) | 0% |
| PARTICULARS | Mar'26 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 101 | ||||||||||
| Debt + | 0 | ||||||||||
| Minority Interest | 0 | ||||||||||
| Trade Payables | 19 | ||||||||||
| Others Liabilities ⓘ | 3 | ||||||||||
| Total Liabilities ⓘ | 123 | ||||||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 28 | ||||||||||
| CWIP ⓘ | 3 | ||||||||||
| Investments ⓘ | 2 | ||||||||||
| Inventories | 16 | ||||||||||
| Trade Receivables | 34 | ||||||||||
| Cash Equivalents | 25 | ||||||||||
| Others Assets ⓘ | 15 | ||||||||||
| Total Assets ⓘ | 123 | ||||||||||
| PARTICULARS | Mar'26 |
|---|---|
| Cash Flow From Operating Activity ⓘ + | 4 |
| Cash Flow From Investing Activity ⓘ + | -25 |
| Cash Flow From Financing Activity ⓘ + | 45 |
| Net Cash Flow ⓘ | 23 |
| PARTICULARS | Mar'26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 20.38 | |||||||||
| ROCE (%) | 27.22 | |||||||||
| Asset Turnover Ratio | 1.19 | |||||||||
| PAT to CFO Conversion(x) | 0.19 | |||||||||
| Working Capital Days | ||||||||||
| Receivable Days | 84 | |||||||||
| Inventory Days | 39.60 | |||||||||
| Payable Days | 117.70 | |||||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Influx Healthtech Ltd FAQs
The current trading price of Influx Healthtech on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Influx Healthtech stood at ₹592.6 Cr
The latest P/E ratio of Influx Healthtech as of 31-Dec-1969 is 28.85.
The latest P/B ratio of Influx Healthtech as of 31-Dec-1969 is 5.88.
The 52-week high of Influx Healthtech is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Influx Healthtech is ₹147 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Influx Healthtech Ltd is a below average quality company.
The key valuation ratios of Influx Healthtech Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Influx Healthtech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Influx Healthtech Ltd
Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as ‘Influx Healthtech Private Limited’ under the provisions of the Companies Act, 2013 with the Registrar of Companies, Central Registration Centre. Pursuant to a special resolution passed by the shareholders at their Extra Ordinary General Meeting held on May 09, 2022, the company was converted from a Private Limited Company to Public Limited Company. Consequently, the name of the company was changed to ‘Influx Healthtech Limited’ and a Fresh Certificate of Incorporation consequent to Conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai.
Influx Healthtech is a Mumbai-based, healthcare focused company specialising in contract manufacturing. Since its inception in 2020, the company has established as a reliable Contract Development and Manufacturing Organization (CDMO), offering specialized services to a wide range of clients across various industries. The company operates manufacturing facilities located in Thane, Maharashtra. These facilities are certified to international quality standards, including GMP (Good Manufacturing Practice), HACCP (Hazard Analysis & Critical Control Points), ISO 22000, and Halal certifications, ensuring adherence to the highest standards of safety,quality and regulatory compliance. These certifications reflect its adherence to stringent safety, quality, and regulatory compliance standards. Equipped with advanced machinery, a dedicated quality control department, and a skilled workforce, its facilities are designed to meet diverse customer needs efficiently and effectively.
Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables.
Business area of the company
The company is engaged in the business of manufacturing and trading of Nutra Products and other related business activities.
Products of the company
- Dietary/Nutritional SUPPLEMENTS
- Cosmetics
- Ayurvedic / Herbal
- Veterinary feeds
- Homecare
Awards and recognition
- 2017: Rotary Vocation Excellence Award 2017-18.
- 2017: Best Third-Party Manufacturing company sports and Nutrition.
- 2018: Most Promising Nutraceutical and Herbal Products Manufacture.
- 2018: Most Promising Nutraceutical and Herbal Product Manufacturer of the year
- 2019: Best Nutaceutical Manufacturer to Dr. Munir Chandniwala, Managing Director of the Company.
- 2023: Best Rotarian of the year 22-23.
History and milestones
- 2020: Incorporation of the Company as a Private Limited Company with the name of ‘Influx Healthtech Private Limited’.
- 2021: Addition in Main Object of a new segment of beauty and cosmetics products, personal care and disinfectant products.
- 2022: Converted to Public Limited Company – consequently the name of the company was changed to ‘Influx Healthtech Limited’.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
